J-Pharma Co.,Ltd. released its earnings results after the market close. For the six months ended September 2026 (April-September), the company posted a non-consolidated net loss of ¥1.31 billion, narrowing from a net loss of ¥1.42 billion in the same period last year.
J-Pharma Co.,Ltd. announced its earnings results after the market close on 11 November. For the six months ended September 2026 (April-September), the company posted a net loss, although the loss narrowed from the same period last year.
Based on these results, and assuming the first-half results reported by the company and its unchanged full-year guidance, we estimated a net loss of ¥1.52 billion for the second half. The loss in the second half of the previous year was ¥1.03 billion.
This article was prepared based on numerical data disclosed by the company and advises investors to review the earnings summary before making investment decisions.